Schedule 13G ownership disclosure
OptimizeRx Corp
Security class unavailable · CUSIP: 68401U204
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,082,776
- Percent of class
- 6.0900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-22-018252
- Form type
- SC 13G
- Filer
- OptimizeRx Corp
- CIK
- CIK 1448431
- Filed
- Feb 10, 2022
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership